A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects

Clinical trial NCT06162169 · COMPLETED

Trial details

NCT number: NCT06162169
Sponsor: Allist Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2023-11-25
Primary completion: 2024-02-20
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.